- Home
- PRCT vs CSQ Comparison
PRCT vs CSQ Comparison
Compare PRCT & CSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCT
- CSQ
- Stock Information
- Founded
- PRCT 2009
- CSQ 2003
- Country
- PRCT United States
- CSQ United States
- Employees
- PRCT N/A
- CSQ N/A
- Industry
- PRCT Medical Specialities
- CSQ Finance Companies
- Sector
- PRCT Health Care
- CSQ Finance
- Exchange
- PRCT Nasdaq
- CSQ Nasdaq
- Market Cap
- PRCT 3.2B
- CSQ 2.7B
- IPO Year
- PRCT 2021
- CSQ N/A
- Fundamental
- Price
- PRCT $58.79
- CSQ $16.22
- Analyst Decision
- PRCT Strong Buy
- CSQ
- Analyst Count
- PRCT 7
- CSQ 0
- Target Price
- PRCT $94.29
- CSQ N/A
- AVG Volume (30 Days)
- PRCT 904.1K
- CSQ 220.3K
- Earning Date
- PRCT 04-24-2025
- CSQ 01-01-0001
- Dividend Yield
- PRCT N/A
- CSQ 7.53%
- EPS Growth
- PRCT N/A
- CSQ N/A
- EPS
- PRCT N/A
- CSQ N/A
- Revenue
- PRCT $224,498,000.00
- CSQ N/A
- Revenue This Year
- PRCT $46.28
- CSQ N/A
- Revenue Next Year
- PRCT $32.67
- CSQ N/A
- P/E Ratio
- PRCT N/A
- CSQ N/A
- Revenue Growth
- PRCT 64.84
- CSQ N/A
- 52 Week Low
- PRCT $45.56
- CSQ $12.50
- 52 Week High
- PRCT $103.81
- CSQ $16.45
- Technical
- Relative Strength Index (RSI)
- PRCT 43.67
- CSQ 39.30
- Support Level
- PRCT $56.14
- CSQ $16.10
- Resistance Level
- PRCT $64.38
- CSQ $16.98
- Average True Range (ATR)
- PRCT 2.76
- CSQ 0.27
- MACD
- PRCT 0.80
- CSQ 0.07
- Stochastic Oscillator
- PRCT 44.05
- CSQ 49.52
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
About CSQ Calamos Strategic Total Return
Calamos Strategic Total Return Fund is a diversified, closed-end management investment company. The fund's objective is to provide total return through a combination of capital appreciation and current income. Its investment portfolio comprises equities, convertible securities, and high-yield corporate bonds.